Shield Therapeutics Share Discussion Threads

[ekcs] 21/5/2020 12:35

Time for people to take a breath and consider the actual situation. None of the information in the RNS is a surprise as they are pretty good at flagging what's coming either through trading updates or interviews on Vox or Proactive etc...

People come and go... the IP, the product and the market it addresses is what counts here… and those things can be clearly assessed from presentations they've shared with all of us previously.

US DEAL:
Getting a US deal done in the current climate must be quite tough for all the obvious logistical complexities coronavirus has created. Plus US players will probably be trying to conserve cash as their reps cannot be out on the road calling on docs, so revenues for non-life-saving/essential products will have reduced for the moment yet STX wants them to pay a multi-million $ upfront... at a time when cash is king. The US is already opening up again so hopefully that is all just transient. So, the company needs to be sure it has the cash such that it doesn't get squeezed in US licence negotiations, which presumably are now well-advanced from their announcements.

As for the CEO...
He had obviously been around since the start, had built the company from nothing and has a very substantial investment (money and time) in the company... no doubt more than all of us... plus he is still in a supportive role for the US project so I guess not getting a salary... Who knows what his personal reasons were for stepping down but they are not relevant as clearly and importantly he is aligned with us lot, as his upside is his 10% stake. What bigger incentive!

Non-Exec Chairman - who knows... who cares... when the company is clearly looking to become a cash cow/royalty play through the US deal.

Stay patient or get out seem to be the options... no point in moaning about an RNS that is basically full of detail that had been flagged already. Looking at the volumes it is just PIs trading, with institutional holders staying put. Tat says a a lot as that's who the company and its brokers will have been/will be talking to.

DYOR.

[peachie 74] 21/5/2020 12:15

Haha. Shergar ... made me laugh.

Good analogy to be fair. I’m not going to say the CEO and chairman stepping back is amazing for the company. But that’s business. And the US deal is taking time. TBF they always said it might as to get the right deal. This will give them cash well into the future hopefully. But yes I’d like the US deal done too.

But I have done a lot of research into iron deficiency and this product as well as others.
And to use your analogy , Feraccru is the Shergar equivalent in the Fe deficiency world. The jockey can improve and change.

But you need the best horse. Shield have IMO

[best1467] 21/5/2020 11:36

That Sherman comment sums it up perfectly and NBG not everyone as been happy for sometime the company as a great product but as been poorly managed and communicated for sometime now.

[kop202] 21/5/2020 11:19

The spread is also eye watering.Seems to vary between 3% and 5%Just to sell and buy back in will cost 6% at least

[daveboy1] 21/5/2020 11:13

Peachie - good points, all of them. I want it to work, trust me (even added today with other funds!) My concern is some other facts that you omitted.
1)CEO and Co-founder departs.
2)New CEO appointed is former CFO, who looks like a fish out of water pre-cooking pot!
3)Dwindling cash described thus 'the cash runway extends into the first quarter of 2021 and there is therefore a material uncertainty which may cast significant doubt on the Group's ability to continue as a going concern' by NEC who then departs. Market reaction seems understandable from this angle to me. It's always 'up in the air' with this company, and it shouldn't be with what they have IMHO. Rather akin to having Shergar with a 16 stone blob sitting on his back !!

[peachie 74] 21/5/2020 11:10

If you sell out at these levels you may well face a struggle getting back in. When the news flow starts , and this gets momentum it flies. We saw that a few weeks ago.

[78steve] 21/5/2020 11:02

I've topped up sub 100p today lets have US mega deal now please

[kop202] 21/5/2020 10:55

The free float is only 30%Volatility is always likely with fewer shares available to trade especially when all trades controlled through MM

[peachie 74] 21/5/2020 10:20

Back to 55p... Please Monty don’t sell them and become an obvious deramper. Sell and move on pal or give justifiably reasons.

In every bit of news flow the company have emphasised that there is fantastic interest in the US and the have multiple options.
So are they blatantly lying to the markets ?
I don’t think so.
Is there another product on the market like this that can compete with IV ? If someone knows please post.
Is iron deficiency a multi billion dollar market. Yes. Fact. Is iron deficiency the worlds biggest deficiency ? Yes. Fact.
And Shield have an effective oral well tolerated product. Fact.

The company may not be moving as quick as people wish , if so move on. All the best.

The small H2H error is the only real negative I can see in relation to the actual product ( and even that isn’t really representative of the product itself ) they actually seem quite bullish about how they can use the rest of the data.
Otherwise , no great failing has been shown with the product itself. It’s BROAD LABEL FDA APPROVED for goodness sake !

Anyway
GLA

[montyhedge] 21/5/2020 10:05

Sold out, back to 55p I think.

[nobbygnome] 21/5/2020 09:59

And a couple of weeks ago everyone was happy when Tim Watts gave a couple of encouraging interviews about an imminent deal. PIs always over react both ways.....it is clear to me this is the time to buy if you are confident they will do a deal at some point in the next 3 or 4 months.

[lako42] 21/5/2020 09:46

Key personnel jumping ship left right and centre. Poor revenue. Poor PR and and a feeling that they are not best placed to get the most from this product.

And every interested US partner well aware that they have dwindling funds that won't last more than 10 months.

All looking rosy

[daveboy1] 21/5/2020 09:08

Not a lot, if I were to hazard a wild, pessimistic guess :-)

[henley2] 21/5/2020 09:05

Takeover won’t happen without the agreement of major 47% shareholder.
Wonder what they think of current performance?

[henley2] 21/5/2020 08:59

Former CEO holds over 10 million shares, so hopefully he is motivated to assist current CEO in sealing a good US deal. Almost 12 months since FDA approval was achieved, progress can at best be described as glacial.

[daveboy1] 21/5/2020 08:58

It's not the drug that worries me as much as the ball-handlers.
I didn't want a t/o before, but I believe that is what needs to happen for the best here as these have bitten off more than they can chew.
How is it being pessimistic when the exact thing happens minutes later lol !
I never went into William Hill to collect my winnings and got called a pessimist before and after striking the wager against the red hot favourite...

[peachie 74] 21/5/2020 08:53

Oh , and a takeover wouldn’t surprise me.

[peachie 74] 21/5/2020 08:51

I didn’t say it wouldn’t ! Just said you were being pessimistic !
This price can swing massively either way , so no real surprise , but it can rise as quick if not quicker than it falls
The end of the day , we have a SAFE drug of proven efficacy. No share ride is easy. This is taking its time. But I truly believe all good things come to those that wait. The market is there for this drug
A massive multi billion pound market.

If you think it won’t succeed , sell.

I do think it will succeed , so I continue to hold as I think potential is huge to take over from the massive IV market

[nobbygnome] 21/5/2020 08:44

I'm buying. Some can't see the wood for the trees!

[daveboy1] 21/5/2020 08:44

Their PR and investor information is poor, and the market is getting tired of it. It's not a patience thing when you can see it being handled sloppily, and esteemed people clearing off! Look at it in the cold light of day :- last summer £1.96 and what did I say not half an hour ago, but got criticised ? 93.95/95.55 (IG) - I rest my case peachie.
Get buying Nobby!!

[best1467] 21/5/2020 08:37

When all said and done something as gone on behind the scenes in a major way my gut feeling is they had a US deal lined up but certain board members we’re of the opinion a better deal was available and the consequences are what we we have now
The current promoted CEO is not a spokesperson as anyone who as witnessed him will agree my problem and dissatisfaction with today’s RNS is while they are results year end 2019 they have given no guidance for 2020 we are approaching June I would have expected some detail on current sales performance.
Regarding US deal as a fellow poster informed me some months ago it looks like they may end up with More than one partner which will make negotiations more complex and time consuming.
I would never imagined 12 months ago been slightly dissatisfied with Shield ignoring the fact it’s been very good financially ,but when all said and done their is still no doubting it’s a good investment around these levels it may just take longer to fully materialise

[frrinvest] 21/5/2020 08:36

Daveboy in case you missed it, in the meantime the planet had shutdown, a reason for the delay?

[daveboy1] 21/5/2020 08:29

I want it to succeed as much as anybody, got a lot in here - just didn't think the NEC's words were very inspiring or uplifting. They've been dangling us on a string for months, and Carl and he have jumped ship. All facts, no pessimism required.

[daveboy1] 21/5/2020 08:22

Thanks for the down tick, but it's coming already !
Not pessimistic, just a lifetime of realistic to avoid the kick in the balls waiting around the corner !